See how Kotak views AI slowdown as a double-edged sword for IT firms, with deflation risks and new AI services opportunities.

AI can help with those tasks. Recursive self-improvement takes that a step further: An AI helps build a successor that is ...

Donald Trump has dismissed warnings regarding artificial intelligence, stressing the critical need for the United States to maintain its lead over China and asserting that whoever wins the AI race ...

Anthropic and OpenAI researchers raised fresh concerns about recursive self-improvement, the process by which AI helps improve the development of models. Both OpenAI and Anthropic have in recent ...

The connected representation of biology those models run on is built once and curated for decades. MindWalk Holdings Corp. is selling the second thing. Twenty years of curation, quantified. HYFT® ...

Plus: OpenAI has paused some model work over safety concerns. This is today's edition of The Download, our weekday newsletter that provides a daily dose of what's going on in the world of technology.

AI agents are not yet creative enough to carry out genuinely innovative open-ended AI research, it seems. The AI industry’s boldest promise right now is that AI will soon improve itself, with almost ...

Artificial intelligence (AI) is poised to reshape pharmaceutical research by addressing some of the industry's most persistent challenges: lengthy timelines, high development costs and substantial ...

Follow this section to personalize your feed and get instant alerts. WHY FOLLOW? Update your preferences in Account Settings Personalized Content Follow this tag to personalize your feed and get ...

Roche and Recursion have pushed their first AI-discovered target for an undisclosed neurodegenerative disease into the next stage. The AI found the target by mining a data map made from over a ...

Roche Holding AG advanced the first project from its AI drug-discovery partnership with Recursion Pharmaceuticals, marking an early test of whether artificial intelligence can uncover new medicines.